What a week in San Diego at DIA 2019! After arriving home late (or early Friday morning) and exhausted from the long journey, I still have an energy coursing through my veins fuelled by the week we left behind. As I reflect what the week meant for us, I feel an excitement about the future of both encapsia and our industry.
Having observed the conference themes and the offerings from other vendors, I can’t help but feel there is nothing quite like encapsia.
Clinical trial sites save time dispensing investigational products using eSource
20 Jun 2019
It is now much easier for clinical trial sites to manage subject data as well as randomization, inventory management and drug dispensation. These processes can now be performed in real time using the single interface and unified database of encapsia, the clinical data suite developed by Cmed’s technology division.
The breakthrough announced today has been made possible by a deep “hyper integration” between encapsia with leading-edge technology platforms PULSE and DRIVE from endpoint Clinical.
Cmed will be at booth #1507 at the DIA 2019 Global Annual Meeting on June 23-27 in San Diego.
Our team on hand will be:
Timothy Corbett-Clark, Chief Technology Officer Catie Roland, Technology Project Manager Jon Carter, Product Manager and Adoption Engineer John O’Brien, Global Head of Business Development All our team at the event are experts with encapsia, the third generation clinical data suite developed by Cmed’s Technology division that enables faster, better and more informed decisions in clinical trials.
The promise of EDC to improve the speed and quality of clinical trials was never really fulfilled. In reality, nothing has fundamentally changed in how clinical trials are conducted. With new hardware, we can begin utilizing tablets such as iPads to directly capture data at site.
Can you imagine the transformation from traditional EDC data collection into eSource with an iPad? eSource is available NOW as part of Cmed’s encapsia clinical data suite - why wait?